These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 1864287

  • 1. Pharmacokinetics of quinolones: newer aspects.
    Wolfson JS, Hooper DC.
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):267-74. PubMed ID: 1864287
    [Abstract] [Full Text] [Related]

  • 2. The pharmacokinetics and tissue penetration of the fluoroquinolones.
    Bergeron MG.
    Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R, Griggs D, Andrews JM.
    Rev Infect Dis; 1988 Feb; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [Abstract] [Full Text] [Related]

  • 4. Quinolone pharmacokinetics and metabolism.
    Lode H, Höffken G, Boeckk M, Deppermann N, Borner K, Koeppe P.
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The clinical pharmacokinetics of levofloxacin.
    Fish DN, Chow AT.
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of fluorinated 4-quinolones in the aged.
    Norrby SR, Ljungberg B.
    Rev Infect Dis; 1989 Feb; 11 Suppl 5():S1102-6. PubMed ID: 2672244
    [Abstract] [Full Text] [Related]

  • 11. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H, Hayakawa I, Akimoto T.
    Yakushigaku Zasshi; 2003 Feb; 38(2):161-79. PubMed ID: 15143768
    [Abstract] [Full Text] [Related]

  • 12. Quinolone-cation interactions: a review.
    Lomaestro BM, Bailie GR.
    DICP; 1991 Nov; 25(11):1249-58. PubMed ID: 1763542
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of the newer fluoroquinolones.
    Brouwers JR.
    Pharm Weekbl Sci; 1987 Dec 11; 9 Suppl():S16-22. PubMed ID: 3325926
    [Abstract] [Full Text] [Related]

  • 14. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA.
    Am J Med; 1992 Apr 06; 92(4A):18S-21S. PubMed ID: 1316065
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG, Well M, Hollauer K, Kirchbauer D, Witte W.
    Chemotherapy; 1998 Apr 06; 44(2):77-84. PubMed ID: 9551236
    [Abstract] [Full Text] [Related]

  • 16. Drug interactions with quinolone antibacterials.
    Brouwers JR.
    Drug Saf; 1992 Apr 06; 7(4):268-81. PubMed ID: 1524699
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of ciprofloxacin.
    Bergan T, Dalhoff A, Rohwedder R.
    Infection; 1988 Apr 06; 16 Suppl 1():S3-13. PubMed ID: 3286512
    [Abstract] [Full Text] [Related]

  • 18. The comparative pharmacokinetics of five quinolones.
    Wise R, Lister D, McNulty CA, Griggs D, Andrews JM.
    J Antimicrob Chemother; 1986 Nov 06; 18 Suppl D():71-81. PubMed ID: 3468102
    [Abstract] [Full Text] [Related]

  • 19. Unique aspects of quinolone pharmacokinetics.
    Lode H, Höffken G, Borner K, Koeppe P.
    Clin Pharmacokinet; 1989 Nov 06; 16 Suppl 1():1-4. PubMed ID: 2653691
    [Abstract] [Full Text] [Related]

  • 20. Tissue penetration and pharmacokinetics of lomefloxacin following multiple doses.
    Kavi J, Stone J, Andrews JM, Ashby JP, Wise R.
    Eur J Clin Microbiol Infect Dis; 1989 Feb 06; 8(2):168-70. PubMed ID: 2498102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.